Hello and Welcome to Patientsville.com, Your Source for all CLOZAPINE information. We are dedicated to provide You with CLOZAPINE safety information. Learn about CLOZAPINE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
CLOZAPINE Safety Reports
Total CLOZAPINE reports: 993.CLOZAPINE FDA safety alerts: 2002 2004 2006 .
Reported deaths: 139 Reported hospitalizations: 169.
Take CLOZAPINE Side Effects Survey or Share Your CLOZAPINE Story. Read More Here.
Showing 1-75 of 993 Next >
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on Aug 23, 2006. Female patient, 50 years of age, was diagnosed with schizophrenia, hypothyroidism and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. CLOZAPINE dosage: 150 MG (150 MG), ORAL. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.CLOZAPINE problem was reported by a Pharmacist from UNITED STATES on Sept 06, 2006. Male patient, 55 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. CLOZAPINE dosage: unknown. Patient recovered.
Physician from UNITED STATES reported CLOZAPINE problem on Oct 19, 2006. Male patient, 35 years of age, weighting 130.0 lb, was diagnosed with schizoaffective disorder, hepatitis c and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, convulsion, neutropenia, pneumonia. CLOZAPINE dosage: unknown. During the same period patient was treated with PEGINTERFERON ALFA, RIBAVIRIN. Patient recovered.
CLOZAPINE problem was reported by a Pharmacist from UNITED STATES on Oct 04, 2006. Male patient, 26 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: myocarditis. CLOZAPINE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on Sept 26, 2006. Female patient, 57 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: convulsion, jaw disorder, weight increased. CLOZAPINE dosage: 25 MG, ORAL. During the same period patient was treated with RISPERDAL, CYMBALTA. Patient recovered.
CLOZAPINE problem was reported by a Physician from NEW ZEALAND on Mar 20, 2007. Female patient, 60 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: influenza like illness, pericardial effusion, pleural effusion, polyserositis, salivary hypersecretion, sedation. CLOZAPINE dosage: 250 MG,. During the same period patient was treated with VALPROATE, VENLAFAXINE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on Mar 22, 2007. Female patient, 70 years of age, was treated with CLOZAPINE. CLOZAPINE dosage: 12.5 MG. Patient was hospitalized. Patient died on 03/01/2007.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2007. Female patient, 46 years of age, was diagnosed with bipolar disorder, schizophrenia, hepatitis and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, condition aggravated, granulocytopenia, influenza like illness, leukopenia, thrombocytopenia. CLOZAPINE dosage: 100 MG; 3 TIMES A DAY; ORAL. During the same period patient was treated with PEGASYS, METFORMIN, TRAZODONE, RIBAVIRIN, NORFLOXACIN. Patient recovered.
Health Professional from GREECE reported CLOZAPINE problem on Mar 19, 2007. Male patient, 33 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: catecholamines urine increased, hypertension, tachycardia, vanillyl mandelic acid urine increased. CLOZAPINE dosage: 600 MG/D. During the same period patient was treated with AMISULPRIDE. Patient recovered.
CLOZAPINE problem was reported by a Physician from ARGENTINA on Mar 20, 2007. Female patient, 36 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, hysterosalpingo-oophorectomy, ovarian cancer. CLOZAPINE dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported CLOZAPINE problem on Mar 29, 2007. Male patient, 47 years of age, weighting 154.3 lb, was diagnosed with schizophrenia, depression and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: colectomy total, intestinal perforation, malaise, megacolon, pain, renal failure, sepsis. CLOZAPINE dosage: unknown. During the same period patient was treated with LOFEPRAMINE, SIMVASTATIN, TERBINAFINE, GLICLAZIDE, LISINOPRIL, NIFEDIPINE. Patient was hospitalized. Patient died on 03/17/2007.
CLOZAPINE problem was reported by a Physician from GERMANY on Mar 21, 2007. Female patient was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: breast cancer, tumour marker increased. CLOZAPINE dosage: UP TO 100 MG, QD. During the same period patient was treated with VENLAFAXINE. Patient recovered.
Consumer or non-health professional from FINLAND reported CLOZAPINE problem on Mar 26, 2007. Male patient, 59 years of age, was diagnosed with mania and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: biliary tract infection, blood test abnormal, c-reactive protein increased, cardiac failure, cholecystitis, cold sweat, dyspnoea, hyperhidrosis, muscular weakness. CLOZAPINE dosage: unknown. During the same period patient was treated with ZYPREXA, ENALAPRIL MALEATE, PLAVIX, DEPAKENE, TRILEPTAL. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Pharmacist from UNITED KINGDOM on Mar 22, 2007. Female patient, 61 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: overweight. CLOZAPINE dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported CLOZAPINE problem on Mar 28, 2007. Female patient, 22 years of age, was diagnosed with schizophrenia, paranoid type and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, gout, hallucination, auditory, monarthritis, paranoia, psychotic disorder, weight increased. CLOZAPINE dosage: 500 MG/D. During the same period patient was treated with ZIPRASIDONE, ALLOPURINOL. Patient recovered.
CLOZAPINE problem was reported by a Health Professional from SWITZERLAND on Mar 28, 2007. Male patient, 33 years of age, was diagnosed with schizophrenia, paranoid type and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, blood triglycerides abnormal, high density lipoprotein decreased, metabolic syndrome, weight increased. CLOZAPINE dosage: unknown. During the same period patient was treated with LEVOMEPROMAZINE. Patient recovered.
Health Professional from UNITED STATES reported CLOZAPINE problem on Mar 27, 2007. Female patient, 33 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: asthenia, dizziness, dizziness postural, somnolence. CLOZAPINE dosage: 200 MG/D. During the same period patient was treated with ETHINYL ESTRADIOL. Patient recovered.
CLOZAPINE problem was reported by a Health Professional from SWITZERLAND on Mar 28, 2007. Female patient, 33 years of age, weighting 167.6 lb, was diagnosed with schizophrenia, paranoid type and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, body mass index increased, fatigue, high density lipoprotein decreased, hypertension, metabolic syndrome, urinary incontinence, weight increased. CLOZAPINE dosage: unknown. During the same period patient was treated with VALPROIC ACID, VALPROIC ACID, RISPERDAL, HALOPERIDOL, ZUCLOPENTHIXOL, PROMAZIN, PENFLURIDOL. Patient recovered.
Physician from SLOVENIA reported CLOZAPINE problem on Mar 26, 2007. Male patient was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction. CLOZAPINE dosage: unknown. Patient recovered.
CLOZAPINE problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Female patient, 16 years of age, was diagnosed with bipolar disorder, schizophrenia, mania and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abasia, aphasia, drooling, incoherent, mania, treatment noncompliance. CLOZAPINE dosage: (625 MG), ORAL. During the same period patient was treated with VALPROATE, QUETIAPINE FUMARATE, LAMOTRIGINE, LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.
Physician from ARGENTINA reported CLOZAPINE problem on Mar 29, 2007. Female patient, 36 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, endometrial cancer stage i, hysterosalpingo-oophorectomy. CLOZAPINE dosage: unknown. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from FRANCE on Apr 05, 2007. Female patient, 35 years of age, weighting 165.3 lb, was diagnosed with schizotypal personality disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, c-reactive protein increased, neutropenia, parotitis, pyrexia, spinal myelogram abnormal, white blood cell count decreased. CLOZAPINE dosage: 300 MG, BID. During the same period patient was treated with DEPAKENE, VICTAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported CLOZAPINE problem on Apr 04, 2007. Male patient, 29 years of age, weighting 145.5 lb, was diagnosed with schizophrenia, paranoid type and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cholestasis, cytolytic hepatitis, hepatic necrosis, intubation, left ventricular failure, leukocytosis, life support, neuroleptic malignant syndrome, neutrophilia. CLOZAPINE dosage: 175 MG/DAY. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Physician from NEW ZEALAND on Mar 21, 2007. Female patient, 43 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain upper, ascites, eosinophilia, heart rate increased, liver disorder, pleural effusion, pyrexia, tenderness. CLOZAPINE dosage: 300 MG PO DAILY. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported CLOZAPINE problem on Mar 29, 2007. Female patient, 74 years of age, was diagnosed with psychotic disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, fall, hip fracture, lethargy, leukocytosis, oral intake reduced. CLOZAPINE dosage: *75 MG), ORAL. During the same period patient was treated with DOCUSATE, CALCIUM CARBONATE, ASCORBIC ACID, SENNA ALEXANDRINA, FLUDROCORTISONE ACETATE, FOLIC ACID, LEVOTHYROXINE, LISINOPRIL. Patient was hospitalized. Patient died on 12/31/2006.
CLOZAPINE problem was reported by a Physician from AUSTRIA on Apr 02, 2007. Male patient was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood calcium increased, blood chloride increased, blood cholesterol increased, blood creatinine increased, blood uric acid increased, eosinopenia, mean cell haemoglobin concentration. CLOZAPINE dosage: 150MG ONCE DAILY. Patient recovered.
Physician from DENMARK reported CLOZAPINE problem on Apr 03, 2007. Male patient, 23 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: leukopenia, lymphocyte count decreased, neutropenia, platelet count increased. CLOZAPINE dosage: 250 MG/D. During the same period patient was treated with ABILIFY, RITALIN, TRUXAL, METHYLPHENIDATE, STRATTERA, EGAZIL DURETTER, NEXIUM. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 19, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, eructation, flatulence, ileus paralytic. CLOZAPINE dosage: unknown. During the same period patient was treated with SERTRALINE. Patient was hospitalized. Patient recovered.
Physician from FINLAND reported CLOZAPINE problem on Apr 04, 2007. Female patient, 53 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hypertension, renal impairment. CLOZAPINE dosage: unknown. Patient recovered.
CLOZAPINE problem was reported by a Physician from FRANCE on Apr 04, 2007. Male patient, 48 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: leukocytosis, lymphocyte count increased, lymphocytic leukaemia. CLOZAPINE dosage: 400 MG PER DAY. During the same period patient was treated with LOXAPAC, LEPTICUR, MYOLASTAN, DAFLON. Patient recovered.
Consumer or non-health professional from GERMANY reported CLOZAPINE problem on Mar 29, 2007. Male patient, 30 years of age, weighting 246.9 lb, was diagnosed with schizophrenia, paranoid type and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: obsessive-compulsive disorder. CLOZAPINE dosage: unknown. During the same period patient was treated with CLOMIPRAMINE. Patient was hospitalized and became disabled. Patient recovered.
CLOZAPINE problem was reported by a Pharmacist from UNITED STATES on Apr 03, 2007. Male patient, 63 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: sepsis. CLOZAPINE dosage: (450 MG), ORAL. Patient died on 03/13/2007.
Health Professional from UNITED STATES reported CLOZAPINE problem on Apr 11, 2007. Male patient, 45 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: anion gap increased, blood bicarbonate decreased, blood glucose increased, blood ketone body increased, blood ph decreased, diabetes mellitus, diabetic ketoacidosis, glycosylated haemoglobin increased. CLOZAPINE dosage: 400 MG/D. During the same period patient was treated with LISINOPRIL, WARFARIN, FUROSEMIDE. Patient died.
CLOZAPINE problem was reported by a Physician from SLOVENIA on Apr 05, 2007. Male patient, weighting 220.5 lb, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction. CLOZAPINE dosage: unknown. During the same period patient was treated with LORSILAN, AKINETON. Patient recovered.
Health Professional from UNITED KINGDOM reported CLOZAPINE problem on Apr 13, 2007. Male patient, 47 years of age, weighting 154.3 lb, was diagnosed with schizophrenia, depression and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: colectomy total, intestinal perforation, malaise, megacolon, pain, renal failure, sepsis. CLOZAPINE dosage: unknown. During the same period patient was treated with LOFEPRAMINE, SIMVASTATIN, TERBINAFINE, GLICLAZIDE, LISINOPRIL, NIFEDIPINE. Patient was hospitalized. Patient died on 03/17/2007.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Male patient, 29 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: anion gap increased, blood bicarbonate decreased, blood glucose increased, blood ketone body increased, blood ph decreased, diabetes mellitus, diabetic ketoacidosis, myocardial infarction, urine ketone body present. CLOZAPINE dosage: 400 MG/D. During the same period patient was treated with DIVALPROEX. Patient died.
Health Professional from UNITED STATES reported CLOZAPINE problem on Mar 30, 2007. Female patient, 46 years of age, weighting 187.0 lb, was diagnosed with bipolar disorder, schizophrenia, hepatitis and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, condition aggravated, granulocytopenia, influenza like illness, leukopenia, thrombocytopenia. CLOZAPINE dosage: 100 MG; 3 TIMES A DAY; ORAL. During the same period patient was treated with PEGASYS, METFORMIN, TRAZODONE, RIBAVIRIN, NORFLOXACIN. Patient was hospitalized and became disabled. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Male patient, 29 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: anion gap increased, blood bicarbonate decreased, blood glucose increased, blood ketone body increased, blood ph decreased, diabetes mellitus, diabetic ketoacidosis, myocardial infarction, urine ketone body present. CLOZAPINE dosage: 400 MG/D. During the same period patient was treated with DIVALPROEX. Patient died.
Consumer or non-health professional from FINLAND reported CLOZAPINE problem on Apr 10, 2007. Female patient, 58 years of age, was diagnosed with schizophrenia, paranoid type, diabetes mellitus non-insulin-dependent and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, alanine aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, decreased appetite, diarrhoea, enterococcal infection, gastrointestinal inflammation. CLOZAPINE dosage: 300 MG/DAY. During the same period patient was treated with AMARYL, DIFORMIN, SIMVASTATIN, PROTAPHAN. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Health Professional from SINGAPORE on Apr 11, 2007. Female patient, 31 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: obsessive-compulsive disorder. CLOZAPINE dosage: 250 MG/D. Patient recovered.
Health Professional from SINGAPORE reported CLOZAPINE problem on Apr 11, 2007. Male patient, 44 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: compulsions. CLOZAPINE dosage: 400 MG/D. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from VENEZUELA on Apr 13, 2007. Male patient, 29 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: lymphocyte count increased, neutrophil count decreased, white blood cell count decreased. CLOZAPINE dosage: 100 MG, UNK. Patient recovered.
Consumer or non-health professional from VENEZUELA reported CLOZAPINE problem on Apr 13, 2007. Male patient, 29 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: lymphocyte count increased, neutrophil count decreased, white blood cell count decreased. CLOZAPINE dosage: 100 MG, UNK. Patient recovered.
CLOZAPINE problem was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient, weighting 190.0 lb, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: eosinophil count increased. CLOZAPINE dosage: 50MG QAM + 50MG Q1PM + 175MG HS PO. During the same period patient was treated with ATIVAN, LITHOBID, PREMARIN, PROCARDIA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on Apr 05, 2007. Male patient, 48 years of age, was diagnosed with bipolar disorder, schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: anaemia, granulocytopenia, leukopenia, lymphoma, shock. CLOZAPINE dosage: unknown. During the same period patient was treated with PAXIL, GLYBURIDE, PREVACID, ACTOS, CRESTOR, LISINOPRIL, LANTUS. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: chills. CLOZAPINE dosage: MATERNAL DOSE: 100 MG/D. During the same period patient was treated with RISPERDAL. Patient recovered.
Physician from BELGIUM reported CLOZAPINE problem on Apr 18, 2007. Female patient was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, fall, pain in extremity. CLOZAPINE dosage: unknown. Patient recovered.
CLOZAPINE problem was reported by a Physician from GERMANY on Apr 16, 2007. Male patient was diagnosed with schizophrenia, disorganised type and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cough, influenza, leukopenia, malaise, monocyte count increased, neutropenia, pyrexia. CLOZAPINE dosage: 400MG/DAY. Patient recovered.
Physician from MALTA reported CLOZAPINE problem on Apr 17, 2007. Female patient, 33 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: full blood count decreased, leukaemia. CLOZAPINE dosage: 400MG DAILY. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 19, 2007. Male patient, 26 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood prolactin increased, fatigue, sedation, weight increased. CLOZAPINE dosage: unknown. During the same period patient was treated with RISPERDAL. Patient recovered.
Physician from MALTA reported CLOZAPINE problem on Apr 17, 2007. Female patient, 33 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: full blood count decreased, leukaemia. CLOZAPINE dosage: 400MG DAILY. Patient recovered.
CLOZAPINE problem was reported by a Pharmacist from UNITED STATES on Apr 27, 2007. Male patient, 21 years of age, weighting 222.0 lb, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count decreased. CLOZAPINE dosage: 150 MG DAILY PO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on Apr 10, 2007. Male patient, 49 years of age, weighting 212.0 lb, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, neutrophil count decreased, white blood cell count decreased. CLOZAPINE dosage: unknown. During the same period patient was treated with FLUOXETINE, HYDROCHLORIDE, ARIPIPRAZOLE, DESMOPRESSIN, OMEPRAZOLE, DILTIAZEM, FUROSEMIDE. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Pharmacist from UNITED STATES on Apr 11, 2007. Female patient, child 9 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cyanosis, fatigue, mood altered, nausea, neutrophil count decreased, skin discolouration, white blood cell count decreased. CLOZAPINE dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, LAMOTRIGINE, ARIPIPRAZOLE, SERTRALINE. Patient recovered.
Physician from AUSTRIA reported CLOZAPINE problem on Apr 27, 2007. Female patient was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, c-reactive protein increased, condition aggravated, glucose tolerance impaired, platelet count increased, white blood cell count increased. CLOZAPINE dosage: 50 MG. During the same period patient was treated with EUTHYROX, KEMADRIN, TRITTICO, TEMESTA, NEXIUM, DOMINALTE. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from FINLAND on Apr 23, 2007. Female patient, 58 years of age, was diagnosed with schizophrenia, paranoid type, diabetes mellitus non-insulin-dependent and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, alanine aminotransferase increased, blood alkaline phosphatase increased, blood sodium decreased, c-reactive protein increased, decreased appetite, diarrhoea, enterococcal infection, gastrointestinal inflammation. CLOZAPINE dosage: 300 MG/DAY. During the same period patient was treated with AMARYL, DIFORMIN, SIMVASTATIN, PROTAPHAN, DUREKAL. Patient was hospitalized. Patient recovered.
Physician from AUSTRIA reported CLOZAPINE problem on May 02, 2007. Female patient was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, c-reactive protein increased, condition aggravated, glucose tolerance impaired, platelet count increased, white blood cell count increased. CLOZAPINE dosage: 50 MG. During the same period patient was treated with EUTHYROX, KEMADRIN, TRITTICO, TEMESTA, NEXIUM, DOMINALTE. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from FRANCE on May 02, 2007. Female patient, 46 years of age, weighting 149.9 lb, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, acquired cardiac septal defect, acute pulmonary oedema, alveolitis, anxiety, blood gases abnormal, blood lactic acid increased, blood pressure immeasurable, bronchial obstruction. CLOZAPINE dosage: 200 MG/DAY. During the same period patient was treated with SEGLOR, TAHOR, AVLOCARDYL, GLUCOPHAGE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on Apr 20, 2007. Female patient, 33 years of age, weighting 208.0 lb, was diagnosed with schizophrenia, paranoid type and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, balance disorder, hallucination, auditory, incorrect dose administered. CLOZAPINE dosage: unknown. During the same period patient was treated with GEODON, HALOPERIDOL DECANOATE, SEROQUEL, XANAX, WELLBUTRIN. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 01, 2007. Male patient, 26 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: blood prolactin increased, fatigue, sedation, weight increased. CLOZAPINE dosage: unknown. During the same period patient was treated with RISPERDAL. Patient recovered.
Health Professional from UNITED STATES reported CLOZAPINE problem on May 03, 2007. Male patient, 38 years of age, was diagnosed with psychotic disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, affect lability, aggression, agitation, atrophy, coordination abnormal, delirium, electroencephalogram abnormal. CLOZAPINE dosage: 600 MG/D. During the same period patient was treated with ZIPRASIDONE, VALPROIC ACID, CHLORAL HYDRATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Health Professional from UNITED STATES on May 03, 2007. Male patient, 38 years of age, was diagnosed with psychotic disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, affect lability, aggression, agitation, atrophy, coordination abnormal, delirium, electroencephalogram abnormal. CLOZAPINE dosage: 600 MG/D. During the same period patient was treated with ZIPRASIDONE, VALPROIC ACID, CHLORAL HYDRATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported CLOZAPINE problem on May 07, 2007. Female patient, weighting 154.3 lb, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension. CLOZAPINE dosage: unknown. During the same period patient was treated with IODINE. Patient recovered.
CLOZAPINE problem was reported by a Physician from GERMANY on May 08, 2007. Male patient, 52 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, pyrexia, urinary tract infection. CLOZAPINE dosage: 150 MG/DAY. Patient recovered.
Consumer or non-health professional from INDIA reported CLOZAPINE problem on Apr 24, 2007. Male patient, 46 years of age, was diagnosed with mania and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: angioedema, blister, flushing, neutrophilia, periorbital oedema, pyrexia, skin exfoliation, white blood cell count increased. CLOZAPINE dosage: (50 MG QD ORAL). Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from INDIA on Apr 24, 2007. Male patient, 45 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: angioedema, neutrophilia, white blood cell count increased. CLOZAPINE dosage: (150 MG QD ORAL). Patient was hospitalized. Patient recovered.
Physician from GERMANY reported CLOZAPINE problem on May 15, 2007. Male patient was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: groin pain, pleurothotonus. CLOZAPINE dosage: 900 MG/DAY. During the same period patient was treated with FLUANXOL. Patient recovered.
CLOZAPINE problem was reported by a Physician from INDIA on May 01, 2007. Female patient, child 1 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: dysphemia, speech disorder developmental. CLOZAPINE dosage: unknown. Patient recovered.
Pharmacist from UNITED STATES reported CLOZAPINE problem on May 18, 2007. Female patient, 48 years of age, weighting 123.5 lb, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CLOZAPINE dosage: 125 MG BID PO. Patient recovered.
CLOZAPINE problem was reported by a Pharmacist from UNITED STATES on May 18, 2007. Female patient, 31 years of age, weighting 196.2 lb, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: tachycardia. CLOZAPINE dosage: 25 MG DAILY PO. Patient recovered.
Physician from UNITED STATES reported CLOZAPINE problem on May 07, 2007. Male patient, 63 years of age, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, respiratory failure, sepsis. CLOZAPINE dosage: 450 MG, ORAL. Patient died on 03/12/2007.
CLOZAPINE problem was reported by a Health Professional from UNITED STATES on May 04, 2007. Female patient, 71 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: pneumonia, small intestinal obstruction. CLOZAPINE dosage: (12.5MG). Patient was hospitalized. Patient died on 03/01/2007.
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on May 02, 2007. Male patient, 48 years of age, was diagnosed with bipolar disorder, schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: anaemia, granulocytopenia, haemodynamic instability, leukopenia, lymphoma, shock. CLOZAPINE dosage: unknown. During the same period patient was treated with PAXIL, GLYBURIDE AND METFORMIN, PREVACID, ACTOS, CRESTOR. Patient was hospitalized. Patient recovered.
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Female patient, 46 years of age, weighting 187.0 lb, was diagnosed with bipolar disorder, schizophrenia, hepatitis and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, granulocytopenia, influenza like illness, leukopenia, liver disorder, thrombocytopenia. CLOZAPINE dosage: 100 MG 3 TIMES A DAY, ORAL. During the same period patient was treated with PEGASYS, METFORMIN, TRAZODONE, RIBAVIRIN, NORFLOXACIN. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CLOZAPINE problem on May 04, 2007. Male patient, 49 years of age, weighting 212.0 lb, was diagnosed with schizophrenia and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, dyspnoea, neutrophil count decreased, white blood cell count decreased. CLOZAPINE dosage: unknown. During the same period patient was treated with FLUOXETINE, HYDROCHLORIDE, ARIPIPRAZOLE, DESMOPRESSIN, OMEPRAZOLE, DILTIAZEM, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 993 Next >